产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 生物制品 生物制剂 Liraglutide for...

Liraglutide for Injection: High-Quality GLP-1 Receptor Agonist for Diabetes Management

2025-06-20

产品详情

Liraglutide for Injection: High-Quality GLP-1 Receptor Agonist for Diabetes Management
其他生物制剂
148866-44-3
中国药典,企业标准
injection
GLP-1 Receptor Agonist,Diabetes Medication,Weight Management,Once-Daily Injection,Type 2 Diabetes Treatment
10mg/Ampoule 15mg/Ampoule 20mg/Ampoule 10Ampoules/Box
中国,北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲

产品描述




Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) analog with 97% amino acid sequence homology to endogenous GLP-1. It functions through several key mechanisms:

  1. Insulin Secretion: Liraglutide binds to GLP-1 receptors on pancreatic beta cells, promoting glucose-dependent insulin secretion to lower blood glucose levels.
  2. Inhibition of Glucagon Secretion: It reduces the secretion of glucagon, thereby decreasing hepatic glucose production.
  3. Delayed Gastric Emptying: Liraglutide slows down gastric emptying, reducing the rapid absorption of glucose from the gastrointestinal tract.
  4. Appetite Regulation: By acting on the central appetite regulation centers in the brain, liraglutide suppresses appetite and increases satiety, leading to reduced food intake.
  5. Beta-Cell Protection: Liraglutide helps protect pancreatic beta-cell function by promoting beta-cell proliferation and reducing apoptosis.

Applications

Liraglutide is primarily used for:

  1. Type 2 Diabetes Treatment: It helps regulate blood glucose levels, reduces HbA1c, and lowers the risk of diabetes-related complications.
  2. Obesity Management: Approved for the treatment of obesity, liraglutide aids in weight loss by suppressing appetite and reducing food intake.
  3. Cardiovascular Protection: Some studies suggest that liraglutide may offer cardiovascular benefits.

Dosage Instructions

  1. For Type 2 Diabetes:The initial dose is typically 0.6 mg once daily, administered via subcutaneous injection.After one week, the dose can be increased to 1.2 mg daily, with a maximum recommended dose of 1.8 mg per day.
  2. For Obesity Treatment:The usual dose is 3.0 mg once daily, administered via subcutaneous injection.It is recommended to inject at the same time each day to maintain stable drug levels.

Storage

  1. Unopened Liraglutide: Should be stored refrigerated (2°C to 8°C) and protected from freezing.
  2. Opened Liraglutide: Can be stored at room temperature (not exceeding 25°C) for up to 28 days after opening.
  3. Avoid exposure to direct sunlight and high temperatures, and keep the medication out of reach of children and pets.


上海浦津林州制药有限公司
访问店铺
注册资本
联系人

公司简介

上海浦津林州制药有限公司,始建于1974年,其前身是林州市市属工业企业--安阳市化学制药厂, 2015年9月更名为“上海浦津林州制药有限公司” 公司位于风景秀丽的太行山东麓,举世闻名的人工天河——红旗渠畔,交通便利,通讯发达。公司占地面积5.5万m2,建筑面积1.9万m2,其中仓储面积3000 m2;厂区绿化面积16000 m2,硬化面积8000 m2。现有职工300余人,固定资产总值6418万元,主导产品主要有葡萄糖酸钙、硫酸镁、维生素C、肌苷等35个注射液品种,在市场上深受广大客户青睐,市场前景广阔。公司为了进一步扩大生产规模,提升产品档次,提高市场占有率,先后投资3.6亿余元,进行技术改造,现在拥有12条符合国家GMP标准的小容量注射剂全自动生产线,并于2014年5月通过国家食品药品监督管理局GMP认证;新建车间年设计生产能力12亿支,可实现产值3亿多元,利税5000余万元。 近年来,公司创新意识不断增强,始终把“技术创新,科技兴厂”作为公司发展的宗旨,企业发展空间大、前景广阔,愿各界同仁、有识之士携手并进,共谋美好未来。